The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line

Cancer Letters

Volumn 135, Issue 1, 1998, Pages 97-105

  Huang, Min ^a   Liu, GengTao ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

5 Fluorouracil; Doxorubicin; Human hepatocellular carcinoma; Innate resistance; Verapamil

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; DNA FRAGMENT; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; PACLITAXEL; VERAPAMIL; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL STRAIN KB; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BISBENZIMIDE; CARCINOMA, HEPATOCELLULAR; DNA; DNA FRAGMENTATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; KB CELLS; LIVER NEOPLASMS; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; VERAPAMIL; VINCRISTINE;

EID: 0032416015     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00280-8     Document Type: Article

References (12)

1. 7402, Acta Biol. Exp. Sin. 11 (1978) 37-45.
2. [2] J. Carmichael, W.G. DeGraff, A.F. Gazdar, J.D. Minna, J.B. Mitchell, Evaluation of a tetralium-based semiautomated colorimetric assay: assessment of chemosensitivity testing, Cancer Res. 47 (1987) 936-942.
3. [3] J.M. Ford, W.C. Prozialeck, W.N. Hait, Structure features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance, Mol. Pharmacol. 35 (1989) 105-115.
4. [4] M. Fang, H.Q. Zhang, S.B. Xue, D.B. Pang, X.S. Chi, Apoptosis resistance and its reversal in Harrigntonine resistant cell line, Acta Pharm. 2 (1994) 891-898.
5. [5] L.J. Greenlund, T.L. Deckwerth, E.M. Johnson Jr., Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death, Neuron 14 (1995) 303-315.
6. [6] V.J. Forrest, Y.H. Kang, D.E. MacClian, D.H. Robinson, N. Pamakrishnan, Oxidative stress-induced apoptosis prevented by trolox, Free Radic. Biol. Med. 16 (1994) 675-684.
7. [7] T. Grogan, W. Dalton, J. Rybski, C. Spier, P. Meltzer, L. Richter, M. Gleason, J. Pindur, A. Cline, R. Scheper, T. Tsuruo, S. Salmon, Optimization of immunocytochemical P-glycoprotein assessment in multidrug resistant plasma cell myeloma using three antibodies, Lab. Invest. 63 (1990) 815-824.
8. [8] J.R. Woodhouse, D.R. Ferry, The genetic basis of resistance to cancer chemotherapy, Ann. Med. 27 (1995) 157-167.
9. [9] K. Isshiki, A. Nakao, M. Ito, M. Hamaguchi, H. Takagi, P-Glycoprotein expression in hepatocellular carcinoma, J. Surg. Oncol. 52 (1993) 21-25.
10. [10] M.M. Gottesman, I. Pastan, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem. 62 (1993) 385-427.
11. [11] W.P. Lee, P-glycoprotein is hyperphosphorylated in multidrug resistant HOB1 lymphoma cells treated with overdose of vincristine, Biochim. Biophys. Acta 1245 (1995) 57-61.
12. [12] A.R. Kinsella, D. Smith, M. Pickard, Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage, Br. J. Cancer 75 (1997) 935-945.